MKKGY News and Press, Merck KGaA ADR

ASNA and Athinia® collaborate to boost semiconductor manufacturing yields through improved data sharing and traceability of subcomponent parts PR Newswire CAMBRIDGE, Mass. , July 8, 2024 /PRNewswire/ -- Today Athinia ® announced a collaboration ...

2024-07-04 03:39:00 ET Summary Merck KGaA remains undervalued with strong fundamentals and diverse business portfolio in healthcare, life sciences, and electronics. The company has above-average margins compared to the broader market, indicating outperformance potential. Despi...

2024-06-25 12:53:48 ET More on Merck KGaA Merck KGaA (MKGAF) Q1 2024 Earnings Call Transcript Historical earnings data for Merck KGaA Dividend scorecard for Merck KGaA Financial information for Merck KGaA Seeking Alpha’s Quant Rating on Merck K...

2024-06-02 14:00:00 ET PD-1/PD-L1 inhibitors, some of the most commonly used cancer therapies, achieved $52B in spending worldwide in 2023, a number expected to reach $90B in 2028. Examples include Merck's ( NYSE: MRK ) Keytruda (pembrolizumab), Bristol Myers Squibb's ( NYSE: BM...

2024-05-15 12:31:02 ET Merck KGaA (MKGAF) Q1 2024 Results Conference Call May 15, 2024 08:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belen Garijo - Chair & CEO Helene von Roeder - CFO Matthias Heinzel - CEO, Life Science Se...

2024-05-15 02:43:44 ET More on Merck KGaA Merck KGaA: Moving To A Hold As 2025 Targets Are Now Doubtful Historical earnings data for Merck KGaA Dividend scorecard for Merck KGaA Financial information for Merck KGaA Read the full article on Seeking A...

2024-04-10 12:49:59 ET Summary Thermo Fisher Scientific, Danaher Corporation, and Agilent Technologies are leading companies in the life science tools industry. Despite a long history of success with those firms, I believe long-term investors should diversify into growth opportuni...

2024-03-24 07:15:00 ET Summary Shanghai WuXi Biologics (HK: 2269) has broken ground on a $1.4 billion facility in Singapore, the first CRDMO to offer end-to-end biologics research, development and manufacturing in the city-state. Novo Nordisk announced plans to invest $556 million...

2024-03-14 10:30:00 ET Summary Merck KGaA's 2023 results were disappointing, with decreased revenue and EBITDA due to challenges in the Process Solutions and Semiconductor Solutions divisions. The company's net income and EPS also decreased in 2023, but adjusted earnings were high...

2024-03-07 12:02:03 ET Merck KGaA (MKGAF) Q4 2023 Results Conference Call March 7, 2024 08:00 AM ET Company Participants Constantin Fest - Head of Investor Relations Belen Garijo - Chair & CEO Helene von Roeder - CFO Matthias Heinzel - CEO, Life Science S...